Skip to main content
Top

Discover Oncology

Issue 6/2011

Special Issue: Adrenal Cancer: Clinical Advances; Guest Editor: Gary D. Hammer, Co-Editors: Martin Fassnacht, Enzo Lalli

Content (11 Articles)

Adrenal Cancer: Clinical Advances

Gary D. Hammer, Martin Fassnacht, Enzo Lalli

The Weiss Score and Beyond—Histopathology for Adrenocortical Carcinoma

Mauro Papotti, Rossella Libè, Eleonora Duregon, Marco Volante, Jerome Bertherat, Frederique Tissier

FDG PET in the Management of Patients with Adrenal Masses and Adrenocortical Carcinoma

Désirée Deandreis, Sophie Leboulleux, Caroline Caramella, Martin Schlumberger, Eric Baudin

Therapeutic Management of Advanced Adrenocortical Carcinoma: What Do We Know in 2011?

E. Baudin, S. Leboulleux, A. Al Ghuzlan, C. Chougnet, J. Young, D. Deandreis, F. Dumont, F. Dechamps, C. Caramella, P. Chanson, E. Lanoy, I. Borget, M. Schlumberger

A debate on laparoscopic versus open adrenalectomy for adrenocortical carcinoma

Francesco Porpiglia, Barbra S. Miller, Matteo Manfredi, Cristian Fiori, Gerard M. Doherty

Metronomic Therapy Concepts in the Management of Adrenocortical Carcinoma

Alfredo Berruti, Paola Sperone, Elisa Bellini, Fulvia Daffara, Paola Perotti, Arianna Ardito, Andrea Saini, Massimo Terzolo

Targeted Therapies for Adrenocortical Carcinoma: IGF and Beyond

Michael J. Demeure, Kimberly J. Bussey, Lawrence S. Kirschner

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.